# Sutro Biopharma, Inc.: Form 8-K, filed Nov 17, 2021

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2021-11-17
- Accepted by EDGAR: Nov 17, 2021, 07:00 ET
- Period: 2021-11-12
- Accession: 0001564590-21-057374
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459021057374/stro-8k_20211112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459021057374/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459021057374/stro-8k_20211112.htm

Filed Nov 17, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-057374. Last ingested by Listed: Nov 13, 2026, 16:35 ET. No prices; not investment advice.
